Anna Lankoff

About

Professor Anna Lankoff is affiliated with the Institute of Nuclear Chemistry and Technology in Poland. Her research focuses on nanotheranostic systems, nanoparticle-based therapeutics, and the implications of radiotherapy in cancer treatment, particularly prostate and gynecological cancers. She has contributed to several recent articles discussing advancements in targeted imaging and therapy, as well as the safety and efficacy of novel radioconjugates and nanomaterials in oncology.